Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831).
Kean JD, Kaufman J, Lomas J, Goh A, White D, Simpson D, Scholey A, Singh H, Sarris J, Zangara A, Stough C. Kean JD, et al. Nutrients. 2015 Dec 2;7(12):9931-45. doi: 10.3390/nu7125507. Nutrients. 2015. PMID: 26633481 Free PMC article. Clinical Trial.
Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial.
Kean JD, Sarris J, Scholey A, Silberstein R, Downey LA, Stough C. Kean JD, et al. Psychopharmacology (Berl). 2017 Feb;234(3):403-420. doi: 10.1007/s00213-016-4471-y. Epub 2016 Dec 5. Psychopharmacology (Berl). 2017. PMID: 27921139 Free PMC article. Clinical Trial.
An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
Downey LA, Kean J, Nemeh F, Lau A, Poll A, Gregory R, Murray M, Rourke J, Patak B, Pase MP, Zangara A, Lomas J, Scholey A, Stough C. Downey LA, et al. Phytother Res. 2013 Sep;27(9):1407-13. doi: 10.1002/ptr.4864. Epub 2012 Dec 19. Phytother Res. 2013. PMID: 23281132 Clinical Trial.
A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
Kean JD, Camfield D, Sarris J, Kras M, Silberstein R, Scholey A, Stough C. Kean JD, et al. Nutr J. 2013 Jul 16;12:100. doi: 10.1186/1475-2891-12-100. Nutr J. 2013. PMID: 23866813 Free PMC article. Clinical Trial.